...
首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model.
【24h】

Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model.

机译:在鼠间皮瘤模型中,调节性T细胞耗竭抑制了化疗周期之间的肿瘤细胞重新聚集。

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: Malignant pleural mesothelioma is a highly aggressive cancer with poor prognosis. We have previously demonstrated that regulatory T cells (Treg) depletion can impact tumor microenvironment when combined with chemotherapy. The aim of this study is to analyze the impact of Treg depletion on tumor cell repopulation during cycles of chemotherapy in a murine mesothelioma model. METHODS: Tumor-bearing mice were treated with chemotherapy once weekly to mimic clinical settings and with PC61 to cause Treg depletion after each cycle of chemotherapy. Tumor cell repopulation was evaluated by BrdU labeling index with immunohistochemistry and flow cytometry, and Ki67 gene expression was determined by real-time reverse-transcribed polymerase chain reaction. The proportion of CD4+ CD25+Foxp3+ Tregs, CD4+, and CD8+ T cells in the tumor, spleen, draining lymph node, and peripheral blood from tumor-bearing mice was determined by using flow cytometry, and gene expression of activated T-cell-related cytokines was quantified by enzyme-linked immunosorbent assay and reverse-transcribed polymerase chain reaction. RESULTS: Tumor growth delay was achieved by cisplatin followed by PC61 or cyclophosphamide. The BrdU labeling index indicated that tumor cell repopulation between cycles of cisplatin was significantly inhibited by PC61. The CD4+CD25+Foxp3+ Tregs in tumor and lymphoid organs were almost completely depleted, whereas the CD4+ or CD8+ T cells did not change. PC61 after chemotherapy resulted in an increase of gene expression of interferon-gamma, granzyme B, perforin, and IP-10, thus leading to tumor cell lysis in cytotoxic lymphocyte assay. Nevertheless, cell killing induced by cyclophosphamide combined with cisplatin was due to cytotoxicity rather than specific immune response. CONCLUSION: Treg depletion between cycles of chemotherapy could improve the outcome of mesothelioma. Nevertheless, this effect seems limited, and more effective approaches need to be developed.
机译:简介:恶性胸膜间皮瘤是一种高度侵袭性的癌症,预后较差。我们先前已经证明,与化学疗法联合使用时,调节性T细胞(Treg)耗竭会影响肿瘤的微环境。这项研究的目的是分析鼠间皮瘤模型中化疗期间Treg耗竭对肿瘤细胞重新聚集的影响。方法:荷瘤小鼠每周接受一次化疗以模拟临床环境,并在每次化疗后用PC61引起Treg耗竭。用免疫组织化学和流式细胞术通过BrdU标记指数评估肿瘤细胞的重新聚集,并通过实时逆转录聚合酶链反应确定Ki67基因表达。使用流式细胞仪测定来自荷瘤小鼠的肿瘤,脾脏,引流淋巴结和外周血中CD4 + CD25 + Foxp3 + Treg,CD4 +和CD8 + T细胞的比例,并测定活化T细胞相关基因的表达通过酶联免疫吸附测定和逆转录聚合酶链反应对细胞因子进行定量。结果:顺铂,PC61或环磷酰胺可达到肿瘤生长延迟。 BrdU标记指数表明PC61显着抑制了顺铂循环之间的肿瘤细胞重新聚集。肿瘤和淋巴器官中的CD4 + CD25 + Foxp3 + Treg几乎完全耗尽,而CD4 +或CD8 + T细胞没有改变。化疗后的PC61导致干扰素-γ,颗粒酶B,穿孔素和IP-10的基因表达增加,从而导致细胞毒性淋巴细胞分析中的肿瘤细胞裂解。尽管如此,环磷酰胺联合顺铂诱导的细胞杀伤是由于细胞毒性而不是特异性免疫反应。结论:化疗周期之间的Treg耗竭可以改善间皮瘤的预后。但是,这种效果似乎有限,需要开发更有效的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号